Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 38.01%
March 31, 2026 33.79%
December 31, 2025 38.82%
September 30, 2025 41.71%
June 30, 2025 40.24%
March 31, 2025 37.76%
December 31, 2024 41.86%
September 30, 2024 41.66%
June 30, 2024 41.53%
March 31, 2024 38.25%
December 31, 2023 43.30%
September 30, 2023 42.85%
June 30, 2023 42.41%
March 31, 2023 42.06%
December 31, 2022 46.70%
September 30, 2022 49.81%
June 30, 2022 50.02%
March 31, 2022 49.35%
December 31, 2021 45.79%
September 30, 2021 46.60%
June 30, 2021 49.56%
March 31, 2021 49.48%
December 31, 2020 51.46%
September 30, 2020 46.02%
June 30, 2020 43.52%
Date Value
March 31, 2020 43.70%
December 31, 2019 45.23%
September 30, 2019 43.64%
June 30, 2019 44.89%
March 31, 2019 40.61%
December 31, 2018 46.40%
September 30, 2018 43.36%
June 30, 2018 44.85%
March 31, 2018 40.32%
December 31, 2017 43.41%
September 30, 2017 41.72%
June 30, 2017 42.40%
March 31, 2017 39.97%
December 31, 2016 43.88%
September 30, 2016 43.27%
June 30, 2016 42.92%
March 31, 2016 39.97%
December 31, 2015 43.72%
September 30, 2015 40.66%
June 30, 2015 42.29%
March 31, 2015 40.85%
December 31, 2014 41.26%
September 30, 2014 42.64%
June 30, 2014 40.99%
March 31, 2014 39.90%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Sysmex Corp. 50.74%
IDEXX Laboratories, Inc. 64.07%
Neogen Corp. 37.03%
QuidelOrtho Corp. 35.75%
Trinity Biotech Plc 0.00%